News
Neural stem cells attack glioblastoma cells
July 6, 2010 10:37 am | by EurekAlert | Comments(Helmholtz Association of German Research Centres) In their latest research, scientists of the Max Delbrueck Center Berlin-Buch, Germany, have demonstrated how the brain's own stem cells and precursor cells control the growth of glioblastomas. Of all brain tumors, glioblastomas are...
EU regulators push Shire drug over Genzyme
July 6, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | CommentsIn a blow to Cambridge-based Genzyme Corp., the European Union's chief drug regulator said Tuesday that doctors should not prescribe a Genzyme drug to new patients because of continuing shortages. The European Medicines Agency said that physicians should instead prescribe a competing drug...
AlloCure appoints new CEO Brenner to head new Burlington HQ
July 6, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | CommentsBiotech startup AlloCure Inc., a developer of cell therapy to treat kidney disease, has named Robert Brenner as its new president and CEO to lead the company in its new Burlington headquarters.
Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries)
July 6, 2010 10:35 am | by Bio-Medicine.Org | CommentsNEW YORK , July 6 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) http://www.reportlinker.com/p0196554/European-Markets-for-Gastrointestin......
ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
July 6, 2010 10:35 am | by Bio-Medicine.Org | CommentsCHICAGO , July 6 /- ICAP Ocean Tomo , the intellectual property brokerage division of ICAP plc (IAP.L), has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc. The portfolio includes over 90 issued US and foreign patents and patent...
Koch Institute, N.J. pharma partner on tumor research
July 6, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | CommentsMIT's David H. Koch Institute of Integrative Cancer Research is partnering with Ortho-McNeil-Janssen Pharmaceuticals Inc. over cancer research and technology, and specifically the study of tumor microenvironments.
3M buys U.K. protective clothing supplier Dailys
July 6, 2010 9:45 am | by The Associated Press | Comments3M Co. the diversified manufacturer whose products include Scotch tape and Post-it Notes, said Tuesday it bought protective clothing supplier Dailys Ltd. for an undisclosed amount.Dailys has 26 employees and is located in Ellesmere Port in the U.K.Shares of 3M rose 59 cents to $78.26 in...
C.R. Bard closes $200 M acquisition of SenoRx
July 6, 2010 8:45 am | by The Associated Press | CommentsC.R. Bard has closed on its acquisition of SenoRx, the medical device maker said Tuesday.SenoRx makes devices used in detecting and treating breast cancer and in May, Bard announced it would buy the company for about $200 million.SenoRx's products include the EnCor breast biopsy system, Gel...
CDRH Forum for International Medical Device Regulatory Authorities - Advanced Session, September 13-15, 2010
July 6, 2010 7:34 am | by U.S. Food & Drug Administration | CommentsCDRH is pleased to announce an advanced session of the CDRH Forum for International Medical Device Regulatory Authorities scheduled for September 13-15, 2010. The CDRH Forum is established for the exchange of medical device regulatory information...
CNT lasers come into view
July 6, 2010 6:37 am | by I-Micronews | CommentsLasers made from carbon nanotubes could soon become a reality thanks to new work by researchers in France.
TowerJazz and Vishay Intertechnology expand relationship to include planar MOSFET and super junction MOSFET devices
July 6, 2010 6:37 am | by I-Micronews | CommentsTowerJazz, a specialty foundry, and Vishay Intertechnology,a low-voltage power MOSFETs producer, report the expansion of their business relationship to include planar MOSFETs and Super Junction FET Power MOSFETs.
Curis lands $3M milestone payment
July 6, 2010 6:36 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge biotech Curis Inc. is lined up to receive a $3 million milestone payment after the company marked its fifth patient treatment in a Phase 1 clinical trial led by licensee Debiopharm SA.
Reportlinker Adds Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities
July 6, 2010 6:36 am | by Bio-Medicine.Org | CommentsNEW YORK , July 6 /- Reportlinker.com announces that a new market research report is available in its catalogue: Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities http://www.reportlinker.com/p0233679/Surgical-Equipment-Market-to-2016--......
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
July 6, 2010 6:36 am | by Bio-Medicine.Org | CommentsDETROIT , July 6 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). This sterile...
Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
July 6, 2010 6:35 am | by Bio-Medicine.Org | CommentsDANBURY, Conn. , July 6 /- Biodel Inc. (Nasdaq: BIOD ) announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 37th Annual Meeting and Exposition of the Controlled Release Society in...
